BRITTANY BRADSHAW: Open Payments
NPI 1538730957 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 27 payments from 7 companies in 2025. Trend: 2023 $15 · 2024 $16 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $235 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| SANOFI PASTEUR INC. | 2 | $48 |
| Lilly USA, LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
Products named: BOTOX, FARXIGA, QULIPTA, BREZTRI, FLUZONE HIGH-DOSE, FLUZONE TRIVALENT, MOUNJARO, OFEV.
Industry payments across TX — which companies pay providers there.
